The follow-on investment underscores confidence in Hill Research’s ability to bridge the gap between agentic AI and life sciences. The company's flagship platform, TriClick, automates the transition from locked clinical databases to regulatory filings, a process that historically suffers from bottlenecks. By generating submission-ready outputs up to 300 times faster than traditional methods, the software addresses critical efficiency gaps for pharmaceutical companies and contract research organizations.
Covenant Doubles Down on Hill Research Amidst Explosive AI Growth
A fourfold revenue surge between 2024 and 2025 has triggered a fresh capital injection into Princeton-based Hill Research. Backed by Covenant and the New Jersey Economic Development Authority’s Evergreen Innovation Fund, the firm is scaling its TriClick platform to accelerate clinical trial biostatistics and FDA regulatory submissions.
René Bastón, a venture partner at Covenant, noted that the firm’s commitment is driven by Hill Research’s fusion of automated statistical programming with rigorous regulatory compliance. This technical edge has already yielded industry recognition, including a spot on the 2026 Innovate100 list and a keynote presence at the 40th AAAI Conference on Artificial Intelligence. With the new funding, CEO Louise Liu plans to expand platform capabilities and operational reach, targeting a five-to-eightfold revenue increase throughout 2026.
Comments (0)
No comments yet. Be the first!